Drug Dermatitis

Nemluvio

Payments companies reported to CMS as associated with Nemluvio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Massociated payments (2023-2025)
14,141clinicians with associated payments
1company reporting

By year

2025 $11M

Payments reported as associated with Nemluvio, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Dermatology $7.7M
Physician Assistant $716K
Mohs-Micrographic Surgery $294K
Medical $277K
Family $254K
Procedural Dermatology $187K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Nemluvio

These are the largest totals companies reported as associated with Nemluvio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Naiem Issa Vienna, VA Dermatology $176,715.92
Jenny Murase Mountain View, CA Dermatology $150,598.58
Peter Lio Chicago, IL Dermatology $136,390.21
Jonathan Silverberg Washington, DC Dermatology $135,554.40
Gloria Lin Jersey City, NJ Dermatology $131,900.16
Diego Dasilva Virginia Beach, VA Dermatology $122,161.79
Sam Awan Plano, TX Dermatology $115,289.91
Omar Noor Somerset, NJ $114,733.55
James Del Rosso Las Vegas, NV Mohs-Micrographic Surgery $100,776.14
Ganary Dabiri Milford, MA Dermatology $100,718.05

Prescribed Nemluvio?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.